Full Text
The Full Text of this article is available as a PDF (159.2 KB).
. 2007 Dec 1;7(6):632–635. doi: 10.7861/clinmedicine.7-6-632
Molecularly targeted therapy in myeloid leukaemias
Charles Craddock
1
Charles Craddock, FRCP FRCPath DPhil
1Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham
Consultant Haemato-oncologist
Find articles by Charles Craddock
1Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham
Roles
Charles Craddock: FRCP FRCPath DPhil, Consultant Haemato-oncologist
KEY WORDS: acute myeloid leukaemia, chronic myeloid leukaemia, targeted therapy, tyrosine tinase inhibitor
© 2007 Royal College of Physicians
PMCID: PMC4954375 PMID: 18193718